AC Immune SA (NASDAQ:ACIU) Short Interest Up 24.4% in July

Share on StockTwits

AC Immune SA (NASDAQ:ACIU) saw a significant growth in short interest in July. As of July 31st, there was short interest totalling 600,600 shares, a growth of 24.4% from the June 30th total of 482,900 shares. Approximately 1.9% of the company’s shares are short sold. Based on an average trading volume of 112,300 shares, the days-to-cover ratio is presently 5.3 days.

Shares of AC Immune stock opened at $5.41 on Thursday. AC Immune has a 1 year low of $3.25 and a 1 year high of $12.50. The stock has a 50-day simple moving average of $5.48. The company has a market capitalization of $368.89 million, a P/E ratio of -6.60 and a beta of 0.02. The company has a quick ratio of 5.06, a current ratio of 5.06 and a debt-to-equity ratio of 0.01.

AC Immune (NASDAQ:ACIU) last announced its quarterly earnings results on Wednesday, May 15th. The company reported $0.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.20 by ($0.36). The business had revenue of $75.28 million during the quarter, compared to the consensus estimate of $106.81 million. AC Immune had a return on equity of 12.17% and a net margin of 29.66%. On average, equities research analysts expect that AC Immune will post 0.17 EPS for the current fiscal year.

Hedge funds have recently bought and sold shares of the company. Cubist Systematic Strategies LLC acquired a new position in shares of AC Immune during the second quarter worth about $58,000. Squarepoint Ops LLC acquired a new position in shares of AC Immune during the fourth quarter worth about $121,000. Appleton Partners Inc. MA acquired a new position in shares of AC Immune during the second quarter worth about $85,000. Marshall Wace North America L.P. boosted its position in shares of AC Immune by 625.8% during the first quarter. Marshall Wace North America L.P. now owns 15,836 shares of the company’s stock worth $80,000 after buying an additional 13,654 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of AC Immune by 20.7% during the second quarter. JPMorgan Chase & Co. now owns 18,162 shares of the company’s stock worth $99,000 after buying an additional 3,113 shares during the period. 26.53% of the stock is owned by institutional investors.

ACIU has been the subject of several recent analyst reports. ValuEngine upgraded AC Immune from a “sell” rating to a “hold” rating in a report on Wednesday, June 12th. HC Wainwright set a $8.00 price target on AC Immune and gave the stock a “buy” rating in a report on Friday, July 12th. Finally, BidaskClub upgraded AC Immune from a “hold” rating to a “buy” rating in a report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $11.94.

About AC Immune

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops therapeutic and diagnostic products for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.

Featured Story: Producer Price Index (PPI)

Receive News & Ratings for AC Immune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Markel Corp Acquires 2,400 Shares of JPMorgan Chase & Co.
Markel Corp Acquires 2,400 Shares of JPMorgan Chase & Co.
Walt Disney Co  is K.J. Harrison & Partners Inc’s 10th Largest Position
Walt Disney Co is K.J. Harrison & Partners Inc’s 10th Largest Position
Walt Disney Co  Holdings Boosted by Matthew Goff Investment Advisor LLC
Walt Disney Co Holdings Boosted by Matthew Goff Investment Advisor LLC
McKinley Carter Wealth Services Inc. Has $1.34 Million Position in Cisco Systems, Inc.
McKinley Carter Wealth Services Inc. Has $1.34 Million Position in Cisco Systems, Inc.
Qube Research & Technologies Ltd Lowers Stock Holdings in Cisco Systems, Inc.
Qube Research & Technologies Ltd Lowers Stock Holdings in Cisco Systems, Inc.
Cisco Systems, Inc.  Shares Sold by Quest Capital Management Inc. ADV
Cisco Systems, Inc. Shares Sold by Quest Capital Management Inc. ADV


© 2006-2019 Ticker Report